Healthcare provider profile · identity verified

Carrie Wojick, MD

Family Practice · RED WING, MN · NPI 1023545829

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	355	120
Levothyroxine Sodium	Levothyroxine Sodium	252	68
Losartan Potassium	Losartan Potassium	238	85
Rosuvastatin Calcium	Rosuvastatin Calcium	231	74
Amlodipine Besylate	Amlodipine Besylate	209	75
Lisinopril	Lisinopril	209	78
Omeprazole	Omeprazole	201	70
Metoprolol Succinate	Metoprolol Succinate	166	56
Gabapentin	Gabapentin	127	44
Simvastatin	Simvastatin	123	38
Eliquis	Apixaban	112	37
Hydrochlorothiazide	Hydrochlorothiazide	108	35
Metformin Hcl Er	Metformin Hcl	108	31
Pantoprazole Sodium	Pantoprazole Sodium	104	36
Trazodone Hcl	Trazodone Hcl	99	39
Duloxetine Hcl	Duloxetine Hcl	98	34
Oxycodone Hcl	Oxycodone Hcl	97	26
Furosemide	Furosemide	89	29
Pravastatin Sodium	Pravastatin Sodium	88	28
Tamsulosin Hcl	Tamsulosin Hcl	82	32
Montelukast Sodium	Montelukast Sodium	78	25
Metoprolol Tartrate	Metoprolol Tartrate	76	31
Spironolactone	Spironolactone	76	23
Albuterol Sulfate Hfa	Albuterol Sulfate	75	31
Ezetimibe	Ezetimibe	73	30
Fluoxetine Hcl	Fluoxetine Hcl	72	17
Allopurinol	Allopurinol	65	19
Alendronate Sodium	Alendronate Sodium	63	22
Metformin Hcl	Metformin Hcl	61	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	14
Ozempic	Semaglutide	60	13
Tramadol Hcl	Tramadol Hcl	60	18
Fluticasone Propionate	Fluticasone Propionate	54	28
Sertraline Hcl	Sertraline Hcl	54	21
Jardiance	Empagliflozin	52	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	21
Triamcinolone Acetonide	Triamcinolone Acetonide	51	33
Glipizide Er	Glipizide	49	17
Pregabalin	Pregabalin	49	22
Trulicity	Dulaglutide	48	suppressed
Atenolol	Atenolol	47	16
Potassium Chloride	Potassium Chloride	47	20
Xarelto	Rivaroxaban	47	14
Zolpidem Tartrate	Zolpidem Tartrate	45	18
Carvedilol	Carvedilol	40	12
Torsemide	Torsemide	40	13
Bupropion Xl	Bupropion Hcl	39	15
Irbesartan	Irbesartan	39	11
Lorazepam	Lorazepam	39	14
Quetiapine Fumarate	Quetiapine Fumarate	39	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	14
Escitalopram Oxalate	Escitalopram Oxalate	38	12
Famotidine	Famotidine	38	13
Mirtazapine	Mirtazapine	38	14
Clonazepam	Clonazepam	37	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Alprazolam	Alprazolam	36	12
Methocarbamol	Methocarbamol	36	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	34	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Chlorthalidone	Chlorthalidone	33	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	15
Amitriptyline Hcl	Amitriptyline Hcl	31	12
Citalopram Hbr	Citalopram Hydrobromide	31	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Ibandronate Sodium	Ibandronate Sodium	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	13
Warfarin Sodium	Warfarin Sodium	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	17
Doxycycline Hyclate	Doxycycline Hyclate	29	19
Prednisone	Prednisone	29	19
Meloxicam	Meloxicam	28	11
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	12
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Amoxicillin	Amoxicillin	21	16
Fluconazole	Fluconazole	21	14
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Nitroglycerin	Nitroglycerin	20	13
Synthroid	Levothyroxine Sodium	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Estradiol	Estradiol	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Cefdinir	Cefdinir	18	15
Celecoxib	Celecoxib	18	suppressed
Nystatin	Nystatin	18	suppressed
Ondansetron Odt	Ondansetron	18	12
Buspirone Hcl	Buspirone Hcl	17	suppressed
Glipizide	Glipizide	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Methylprednisolone	Methylprednisolone	16	suppressed
Movantik	Naloxegol Oxalate	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Ramelteon	Ramelteon	15	suppressed
Temazepam	Temazepam	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error